Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Aquestive Therapeutics, Inc.:

We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG

New York, New York

September 11, 2019